| Dr Jennifer Margaret Carman, MD | |
|
3300 W Centre Ave, Portage, MI 49024-4666 | |
| (269) 327-2211 | |
| (269) 327-0273 |
| Full Name | Dr Jennifer Margaret Carman |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 21 Years |
| Location | 3300 W Centre Ave, Portage, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952453474 | NPI | - | NPPES |
| 1417961137 | Other | MI | BCBSM - BMH |
| 1952453474 | Medicaid | MI | |
| 5177480 | Medicaid | MI | |
| 5177461 | Medicaid | MI | |
| 5177470 | Medicaid | MI | |
| 1235131137 | Other | MI | BCBSM - BLH |
| 5177499 | Medicaid | MI | |
| 1104840529 | Other | MI | BCBSM - BPM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301081704 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bronson Methodist Hospital | 0244148633 | 598 |
News Archive
Increased Medicare payments to physicians for outpatient surgeries for bladder cancer have led to a dramatic rise in the number of these procedures being performed and an overall increase in cost to the healthcare system. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The findings indicate that some Medicare policies aimed at decreasing costs may instead be contributing to an increase in healthcare expenditures.
On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) - including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees - discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate).
Salk neuroscientist Terrence J. Sejnowski joined President Barack Obama in Washington, D.C., on April 2, 2013, at the launch of the Brain Research through Advancing Innovative Neurotechnologies Initiative-a major Administration neuroscience effort that advances and builds upon collaborative scientific work by leading brain researchers such as Salk's own Sejnowski.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
The Orlando Sentinel on Wednesday profiled the region's first residential home for transgender people living with HIV, which advocates say helps a "unique community that faces discrimination, ignorance and a disproportionate share" of HIV/AIDS cases. Keith Theriot, program manager for Orlando's Housing and Community Development Department, said that the population is "particularly complicated," adding that officials "really want to have a safe and stable environment for our clients that are in need."
› Verified 7 days ago
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
Increased Medicare payments to physicians for outpatient surgeries for bladder cancer have led to a dramatic rise in the number of these procedures being performed and an overall increase in cost to the healthcare system. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The findings indicate that some Medicare policies aimed at decreasing costs may instead be contributing to an increase in healthcare expenditures.
On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) - including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees - discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate).
Salk neuroscientist Terrence J. Sejnowski joined President Barack Obama in Washington, D.C., on April 2, 2013, at the launch of the Brain Research through Advancing Innovative Neurotechnologies Initiative-a major Administration neuroscience effort that advances and builds upon collaborative scientific work by leading brain researchers such as Salk's own Sejnowski.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
The Orlando Sentinel on Wednesday profiled the region's first residential home for transgender people living with HIV, which advocates say helps a "unique community that faces discrimination, ignorance and a disproportionate share" of HIV/AIDS cases. Keith Theriot, program manager for Orlando's Housing and Community Development Department, said that the population is "particularly complicated," adding that officials "really want to have a safe and stable environment for our clients that are in need."
› Verified 7 days ago
| Entity Name | Bronson Battle Creek Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093119638 PECOS PAC ID: 0547173478 Enrollment ID: O20041103000774 |
News Archive
Increased Medicare payments to physicians for outpatient surgeries for bladder cancer have led to a dramatic rise in the number of these procedures being performed and an overall increase in cost to the healthcare system. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The findings indicate that some Medicare policies aimed at decreasing costs may instead be contributing to an increase in healthcare expenditures.
On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) - including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees - discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate).
Salk neuroscientist Terrence J. Sejnowski joined President Barack Obama in Washington, D.C., on April 2, 2013, at the launch of the Brain Research through Advancing Innovative Neurotechnologies Initiative-a major Administration neuroscience effort that advances and builds upon collaborative scientific work by leading brain researchers such as Salk's own Sejnowski.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
The Orlando Sentinel on Wednesday profiled the region's first residential home for transgender people living with HIV, which advocates say helps a "unique community that faces discrimination, ignorance and a disproportionate share" of HIV/AIDS cases. Keith Theriot, program manager for Orlando's Housing and Community Development Department, said that the population is "particularly complicated," adding that officials "really want to have a safe and stable environment for our clients that are in need."
› Verified 7 days ago
| Entity Name | Bronson Lakeview Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235131137 PECOS PAC ID: 9032008495 Enrollment ID: O20051027001022 |
News Archive
Increased Medicare payments to physicians for outpatient surgeries for bladder cancer have led to a dramatic rise in the number of these procedures being performed and an overall increase in cost to the healthcare system. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The findings indicate that some Medicare policies aimed at decreasing costs may instead be contributing to an increase in healthcare expenditures.
On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) - including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees - discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate).
Salk neuroscientist Terrence J. Sejnowski joined President Barack Obama in Washington, D.C., on April 2, 2013, at the launch of the Brain Research through Advancing Innovative Neurotechnologies Initiative-a major Administration neuroscience effort that advances and builds upon collaborative scientific work by leading brain researchers such as Salk's own Sejnowski.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
The Orlando Sentinel on Wednesday profiled the region's first residential home for transgender people living with HIV, which advocates say helps a "unique community that faces discrimination, ignorance and a disproportionate share" of HIV/AIDS cases. Keith Theriot, program manager for Orlando's Housing and Community Development Department, said that the population is "particularly complicated," adding that officials "really want to have a safe and stable environment for our clients that are in need."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Margaret Carman, MD 3300 W Centre Ave, Portage, MI 49024-4666 Ph: (269) 327-2211 | Dr Jennifer Margaret Carman, MD 3300 W Centre Ave, Portage, MI 49024-4666 Ph: (269) 327-2211 |
News Archive
Increased Medicare payments to physicians for outpatient surgeries for bladder cancer have led to a dramatic rise in the number of these procedures being performed and an overall increase in cost to the healthcare system. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The findings indicate that some Medicare policies aimed at decreasing costs may instead be contributing to an increase in healthcare expenditures.
On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) - including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees - discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate).
Salk neuroscientist Terrence J. Sejnowski joined President Barack Obama in Washington, D.C., on April 2, 2013, at the launch of the Brain Research through Advancing Innovative Neurotechnologies Initiative-a major Administration neuroscience effort that advances and builds upon collaborative scientific work by leading brain researchers such as Salk's own Sejnowski.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
The Orlando Sentinel on Wednesday profiled the region's first residential home for transgender people living with HIV, which advocates say helps a "unique community that faces discrimination, ignorance and a disproportionate share" of HIV/AIDS cases. Keith Theriot, program manager for Orlando's Housing and Community Development Department, said that the population is "particularly complicated," adding that officials "really want to have a safe and stable environment for our clients that are in need."
› Verified 7 days ago
Sara Lynn Deatsman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3300 W Centre Ave, Portage, MI 49024 Phone: 269-327-2211 Fax: 269-327-0273 | |
Kirsten M Johantgen, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7895 Currier Dr, Portage, MI 49002 Phone: 269-321-7080 | |
Scott Piereson, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7895 Currier Dr, Portage, MI 49002 Phone: 269-321-7080 | |
Dr. Amber Rachelle Nash-guilford, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7895 Currier Dr, Portage, MI 49002 Phone: 269-321-7080 Fax: 269-321-7011 | |
Scott M Peterson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3300 W Centre Ave, Bronson Ob Gyn Associates, Portage, MI 49024 Phone: 269-327-2211 Fax: 269-327-0273 | |
Tempest A Allen, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3300 W Centre Ave, Portage, MI 49024 Phone: 269-327-2211 Fax: 269-327-0273 | |
Steven M Trillet, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3300 W Centre Ave, Portage, MI 49024 Phone: 269-327-2211 Fax: 269-327-0273 |